Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy

PEMD-92-28: Published: Jul 17, 1992. Publicly Released: Aug 17, 1992.

Additional Materials:


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO examined factors that influence where oncologists treat Medicare patients and the potential cost to the federal government of treatment in different settings.

GAO found that: (1) some oncologists have treated cancer patients in hospital inpatient and outpatient settings when, by clinical standards, these patients could have received treatment in the office; (2) oncologists interviewed consistently stated that their choice of treatment setting was influenced by whether they expected reimbursement to be adequate if they provided treatment in the office setting; and (3) treatment in the hospital inpatient setting was more expensive to Medicare than hospital outpatient or office treatment settings.

Sep 29, 2016

Sep 28, 2016

Sep 15, 2016

Sep 14, 2016

Sep 12, 2016

Sep 9, 2016

Sep 6, 2016

Looking for more? Browse all our products here